Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Funds

Offices

HQ
401 Commerce Street
Suite 740
Nashville, TN, 37219
USA

People

Managing Director
Managing Director
Managing Director
Managing Director
Managing Director
President and CEO
Vice President & Controller
Vice President
Show All People

Tags

Iroquois Capital

Iroquois Capital, LP is a private equity and venture capital firm specializing in seed or start-up, early, mid, and late venture; turnarounds; growth capital; and PIPE investments. It seeks to invest in all industries. The firm also manages hedge funds for its clients. Iroquois Capital, LP was founded in 2003 and is based in New York, New York.

Recent Milestones

Investments

Company Date Round Size Participants
Covenant Surgical Partners 2/2013Series C$35M3
Oncothyreon 9/2010Venture Round$14.9M11
Raptor Pharmaceuticals 8/2010Venture Round$15M5
Soligenix 7/2010Venture Round$5.9M9
TapImmune 6/2010Venture Round$1.28M1
Senesco Technologies 3/2010Venture Round$11.5M14
Biomoda 3/2010Venture Round$1M3
SinoHub 2/2010Venture Round$4.61M10
VeriTeQ Corporation 2/2010Venture Round$1.54M2
CEL-SCI 8/2009Venture Round$4.4M7
Agenus 8/2009Venture Round$10M3
ACE*COMM 2007Private Equity$5M8
EUSA Pharma 11/2006Venture Round$18.6M16
Migo Software 3/2006Venture Round$3.98M1
EUSA Pharma 12/2005Venture Round$12.5M5
BravoSolution 8/2005Venture Round$6.5M13
Pharmacopeia 7/2005Venture Round$7.63M10

Videos

Sources

    Iroquois Capital Group raises $13M for investment fund (bizjournals.com) [edit]
  1. Surgery Center Operator Covenant Closes on $35M to Continue Acquisition Spree (pevc.dowjones.com) [edit]
  2. Oncothyreon Announces Pricing of $14.9 Million Private Placement (ir.oncothyreon.com) [edit]
  3. Raptor Pharmaceutical Announces Pricing of $15 Million PIPE Financing (ir.raptorpharma.com) [edit]
  4. SEC (sec.gov) [edit]
  5. SEC (sec.gov) [edit]
  6. Senesco Technologies, Inc. Announces Private Placement Financing for Gross Proceeds of $11.5 Million. Funds to be Utilized to Advance Lead Multiple Myeloma Drug Candidate into Phase 1b/2a Clinical Trial (senesco.com) [edit]
  7. EDGAR [edit]
  8. EDGAR [edit]
  9. EDGAR [edit]
  10. CEL-SCI SIGNS DEFINITIVE AGREEMENT TO RAISE $4.4 MILLION IN REGISTERED DIRECT OFFERING (cel-sci.com) [edit]
  11. SEC (sec.gov) [edit]
  12. Citation Needed [add]
  13. EDGAR [edit]
  14. EDGAR [edit]
  15. EDGAR [edit]
  16. EDGAR [edit]
  17. EDGAR [edit]
Edit This Page
Last Edited 4/16/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy